Aignostics · Series B

Berlin-based computational pathology company building AI foundation models that analyze tissue

Amount

$34M

Round

Series B

Valuation

—

Announced

—

Investors

Lead investor

Participating investors

Mayo Clinic HTGF Wellington Partners Boehringer Ingelheim Venture Fund CARMA Fund IBB Ventures